29
11
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1783 |
LXR-623
LXR623,WAY 252623 |
Liver X Receptor | Metabolism |
LXR-623 (WAY 252623) 是一种LXRα部分激动剂和LXRβ完全激动剂,可透过血脑屏障,IC50分别为 179 nM 和 24 nM 。 | |||
T63723 | LXR agonist 1 | ||
LXR (Liver X receptor) agonist 1 是 LXR 的有效激动剂,能够作用于 LXR-α (AC50: 1.5 nM) 和 LXR-β (AC50: 12 nM)。LXR agonist 1 对动脉粥样硬化表现出研究潜力。 | |||
T64148 | LXR agonist 2 | ||
LXR agonist 2 是 LXR (肝 X 受体) 的有效激动剂。LXR agonist 2 能够稳定 NCOA1 (助激活剂),进而激动 LXR。 | |||
T83128 | Aminooxy CatB-LXR | ||
Aminooxy CatB-LXR (compound 10) 是一种用于抗体药物偶联体(ADC)的药物连接分子。 | |||
T64171 | LXR antagonist 2 | ||
LXR antagonist 2 (compound 10rr) 是一种有效的 LXR (肝 X 受体) 反向激动剂,能够作用于 LXRβ (IC50: 0.36 μM) 和 LXRα (IC50: 2.25 μM)。 LXR antagonist 2 是一种脂肪生成抑制剂,能够下调 LXR 靶基因 SREBP-1c、ACC、FAS 和 SCD-1。LXR antagonist 2 对 Triton WR-1339 诱导的高脂血症小鼠表现出降脂活性。 | |||
T5178 |
AZ876
|
Liver X Receptor | Metabolism |
AZ876 是高亲和力的 LXR 激动剂。它在人的 (h)LXRα 和 hLXRβ 比 GW3965 要分别强 25 和 2.5 倍。 | |||
T16930 |
SR9238
|
Liver X Receptor | Metabolism |
SR9238 是有效的肝 X 受体(LXR)反向激动剂,对LXRα和LXRβ的IC50分别为 214 nM 和 43 nM。 | |||
T1801 |
SR9243
|
Liver X Receptor | Metabolism |
SR9243 是一种 liver-X-receptor 的反向激动剂,可诱导 LXR-辅阻遏物相互作用。 | |||
T15427 |
GSK2033
|
Liver X Receptor | Metabolism |
GSK2033 是LXR 的有效拮抗剂,抑制LXRα和LXRβ的pIC50分别为 7 和 7.4。 | |||
T7768 |
RGX-104
RGX-104 free Acid |
Liver X Receptor | Metabolism |
RGX-104 (RGX-104 free Acid) 是一种口服具有活力的肝X 核激素受体激动剂,通过 ApoE 基因的转录激活调节先天免疫。 | |||
T6310 |
GW3965 hydrochloride
GW3965 HCl |
Liver X Receptor | Metabolism |
GW3965 hydrochloride (GW3965 HCl) 是一种肝 X 受体 (LXR) 激动剂,主要作用于 hLXRα (EC50:190 nM) 和 hLXRβ (EC50:30 nM) | |||
T27478 |
GSK3987
|
Liver X Receptor | Metabolism |
GSK3987 是广谱LXRα/β激动剂,EC50分别为 50 nM 和 40 nM。GSK3987增加 ABCA1 和 SREBP-1c 蛋白的表达,诱导细胞甘油三酯的积累和胆固醇流出。 | |||
T5128 |
RGX-104 hydrochloride
SB742881,RGX-104 HCl,盐酸RGX-104 |
Liver X Receptor | Metabolism |
RGX-104 hydrochloride (SB742881) 是小分子LXR 激动剂,利用 ApoE 基因的转录激活,调节先天免疫。 | |||
T3970 |
BMS-779788
XL652,EXEL04286652,XL 652,XL-652,BMS-788 |
Liver X Receptor | Metabolism |
BMS-779788 (XL-652) 是一种 LXR 的部分激动剂,能够作用于 LXRα (IC50:68 μM) 和 LXRβ (IC50:14 μM)。 | |||
T63989 | LXRβ agonist-3 | ||
LXRβ agonist-3 是一种强效的、选择性的 LXRβ (肝 X 受体 β) 激动剂 (EC50: 0.095 μM)。LXRβ agonist-3 可以有效抑制 U87EGFRvIII 细胞 (IC50: 3.75 μM)。LXRβ agonist-3 表现出抗肿瘤作用,能够抑制恶性胶质瘤。 | |||
T6690 |
T0901317
N-(2,2,2-三氟乙基)-N-[4-[2,2,2-三氟-1-羟基-1-(三氟甲基)乙基]苯基]苯磺酰胺 |
Apoptosis; FXR; Liver X Receptor; ROR | Apoptosis; Metabolism |
T0901317 是一种口服有效且高度选择性的LXR 激动剂,对 LXRα 的EC50为 20 nM。它激活FXR,EC50为 5 μM。它是RORα和RORγ双重反向激动剂,Ki 值分别为 132 nM 和 51 nM。它诱导细胞凋亡,并抑制低密度脂蛋白受体缺失小鼠动脉粥样硬化的发展。 | |||
T11899 |
LXRβ agonist-2
|
Others | Others |
LXRβ agonist-2 is a highly potent and β-selective liver X receptor (LXRβ) agonist with EC50 of 7 nM. | |||
T16792 |
Rovazolac
ALX-101 |
Liver X Receptor | Metabolism |
Rovazolac (ALX-101) 是一种肝脏x受体 (LXR)调节剂,可用于研究免疫系统疾病和特应性皮炎。 | |||
T68316 |
GAC0003A4
GAC0001E5 |
Liver X Receptor | Metabolism |
GAC0003A4 是一种有效的 LXR 反向激动剂,具有抗肿瘤活性,能抑制 LXR 蛋白的转录。GAC0003A4 可降解 LXRβ 蛋白,以剂量依赖性方式抑制PDAC细胞增殖。GAC0003A4 有用于研究晚期胰腺癌和其他顽固性恶性肿瘤。 | |||
T63896 |
BE1218
|
Liver X Receptor | Metabolism |
BE1218 是一种肝 X 受体 (LXR) 反向激动剂,对 LXRα 和 LXRβ有活性,IC50 分别为 9 nM 和 7 nM。 | |||
T40898 |
DMHCA
|
||
DMHCA, a potent, selective LXR agonist, specifically activates the LXR pathway's cholesterol efflux arm, avoiding triglyceride synthesis stimulation. This compound exhibits anti-inflammatory properties and is utilized in researching cholesterol homeostasis and diabetes. | |||
T68696 |
AZ-2
|
||
AZ-2 is an inducer of ABCA1 and apoE. It enhances ABCA1 activity and decreases P2X7 receptor activity. AZ-2 activates endogenous LXR signaling but shows no direct LXRα or LXRβ agonist activity. | |||
T74147 | Larsucosterol (trimethylamine) | ||
Larsucosterol (DUR-928) trimethylamine,一种胆固醇代谢物,有效的肝 X 受体 (LXR) 拮抗剂,同时作为内源性脂肪生成的调节剂。该化合物通过下调 mRNA 水平和抑制 SREBP-1 的激活,有效抑制胆固醇的生物合成。 | |||
T68668 |
AZ-1
|
||
AZ-1 is an inducer of ABCA1 and apoE. It enhances ABCA1 activity and decreases P2X7 receptor activity. AZ-1 activates endogenous LXR signaling but shows no direct LXRα or LXRβ agonist activity. | |||
T69671 | SR1903 TFA | ||
SR-1903 is a modulator of retinoic acid receptor-related orphan receptor γ (RORγ) and liver X receptor (LXR). It is an inverse agonist of RORγ and an agonist of LXR. It also binds to peroxisome proliferator-activated receptor γ (PPAR) but does not activate it. SR-1903 inhibits LPS-induced expression of triggering receptor expressed on myeloid cells 1 (TREM-1). It also inhibits LPS-induced expression of the LXR target genes IL-6 and IL-33 and increases expression of ABCG1, FASN, and SCD-1. SR-190... | |||
T36130 |
22(S)-hydroxy Cholesterol
22(S)-hydroxy Cholesterol,22β-hydroxy Cholesterol |
||
22(S)-hydroxy Cholesterol is a synthetic oxysterol and a modulator of the liver X receptor (LXR). [1] t prevents monocyte chemoattractant protein 1 (MCP-1) expression induced by the LXR agonist GW 3965 in primary hepatocytes and downregulates mRNA expression of the LXR target genes CD36, ACSL1, and SCD-1 in human myotubes. It decreases triacylglycerol and diacylglycerol synthesis from labeled palmitate and acetate, respectively, in human myoblasts by 50% when used at a concentration of 10 uM. 22... | |||
T35638 |
SR 1903
|
||
SR 1903 is a modulator of retinoic acid receptor-related orphan receptor γ (RORγ) and liver X receptor (LXR).1 It is an inverse agonist of RORγ (IC50 = ~100 nM in a cell-based reporter assay) and an agonist of LXR. It also binds to peroxisome proliferator-activated receptor γ (PPARγ; IC50 = 209 nM) but does not activate it. SR 1903 (10 μM) inhibits LPS-induced expression of triggering receptor expressed on myeloid cells 1 (TREM-1) in RAW 264.7 cells. It also inhibits LPS-induced expression of th... | |||
T6310L |
GW3965
|
||
GW3965 是选择性的肝 X 受体 (LXR) 激动剂,对 hLXRα 和 hLXRβ 的 EC50分别为 190 nM 和 30 nM。 | |||
T83765 |
Dendrogenin A
DDA |
||
Dendrogenin A (DDA) 作为一种选择性肝X受体(LXR)调节剂(SLiM)、胆固醇环氧水解酶(ChEH; Ki = 120 nM)的抑制剂及胆固醇的活性代谢产物,通过DDA合成酶将5,6α-环氧胆固醇与组胺结合形成。DDA在非癌性人乳腺上皮细胞和上皮黑色素细胞中存在,但在多种乳腺癌细胞或黑色素瘤细胞中未发现,且在分离的人乳腺肿瘤组织中仅以低水平存在。它抑制22(R)-羟基胆固醇诱导的LXRβ和LXRα激活(分别以IC50 = 76和362 nM),但也是LXR的部分激动剂,在B16/F10小鼠黑色素瘤细胞中增加Nur77、NOR-1、LC3-I和LC3-II的蛋白水平。DDA选择性调节LXRα和LXRβ,而非孕烯X受体(PXR)、芳香烃受体(AhR)、维生素D受体(VDR)、维甲酸X受体γ(RXRγ)、维甲酸受体α(RARα)、过氧化物酶体增殖物激活受体α(PPARα)、PPARγ、糖皮质激素受体、雄激素受体、雌激素受体α(ERα)及ERβ在2.5 µM下。此外,DDA在2.5和5 µM的浓度下增加B16/F10和SK-MEL-28癌细胞中LC3-II的蛋白水平,并在2... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7529 |
Yamogenin
山药 |
Others | Others |
Yamogenin 是一种薯蓣皂素的非对映异构体。它通过抑制 HepG2 肝细胞中脂肪酸合成的基因表达来抑制甘油三酸酯 (TG) 的积累。它在萤光素酶配体测定中拮抗肝脏 X 受体 (LXR) 的激活。 | |||
T2768 |
Saikosaponin A
柴胡皂苷A,柴胡皂苷 A |
NF-κB; Antibacterial; Liver X Receptor | Metabolism; Microbiology/Virology; NF-κB |
Saikosaponin A 是银柴胡中的主要活性成分,有抗炎活性,可上调 LXRα的表达。 | |||
TQ0274 |
27-Hydroxycholesterol
27-羟基胆固醇,5,25R-胆甾烯-3BETA,26-二醇,25(R)-27-hydroxy Cholesterol |
Estrogen/progestogen Receptor; Liver X Receptor | Endocrinology/Hormones; Metabolism |
27-Hydroxycholesterol (25(R)-27-hydroxy Cholesterol) 是一种有效的、选择性的雌激素受体调节剂和肝X 受体激动剂。 | |||
T2810 |
(20S)-Protopanaxatriol
原人参三醇,20(S)-APPT,20 (S)-原人参三醇,g-PPT |
Apoptosis; Estrogen Receptor/ERR; Glucocorticoid Receptor; Estrogen/progestogen Receptor; Liver X Receptor | Apoptosis; Endocrinology/Hormones; Metabolism |
(20S)-Protopanaxatriol (g-PPT) 是人参皂苷的代谢物,通过糖皮质激素受体和雌激素受体起作用,同时为LXRα的抑制剂,具有广泛的抗癌活性。 | |||
TN2359 |
Iristectorigenin B
Iristectrigenin B |
Liver X Receptor | Metabolism |
Iristectorigenin B (Iristectrigenin B) 是一种有效的肝脏 X 受体 (LXR) 调节剂,是从 Belamcanda chinensis 中分离的小分子化合物。Iristectrigenin B 可促进巨噬细胞 RAW 1.1 细胞中 ABCA264 和 ABCG7 的表达。 | |||
T10086 |
24-Hydroxycholesterol
Cholest-5-ene-3beta,24-diol |
Liver X Receptor; NMDAR | Metabolism; Neuroscience |
24-Hydroxycholesterol (Cholest-5-ene-3beta,24-diol) 是一种氧甾醇化合物,是一种 n-甲基-d-天门冬氨酸受体 (NMDA) 和转录因子 LXR 的激活剂,可用于研究心血管生成和胰腺癌。 | |||
T5743 |
Gymnemagenin
|
Liver X Receptor | Metabolism |
Gymnemagenin 是一种分离自G. sylvestre 的三萜。 它具有抗病毒作用,对糖尿病和肥胖症具有潜在的研究价值。 | |||
T16264 | Nagilactone B | Others | Others |
Nagilactone B is extracted from the root bark of Podocarpus nagi and it also is a liver X receptor (LXR) agonist. | |||
TN4016 |
Ethyl 2,4,6-trihydroxybenzoate
|
Liver X Receptor | Metabolism |
Ethyl 2,4,6-trihydroxybenzoate is a dual-LXR modulator that regulates the expression of key genes in cholesterol homeostasis in multiple cells without inducing lipid accumulation in HepG2 cells. It suppresses cellular cholesterol accumulation in a dose-dependent manner and induces the transcriptional activation of LXR-α/-β-responsive genes. | |||
T28021 | meso-Dihydroguaiaretic acid | ||
meso-Dihydroguaiaretic acid is an LXR-α antagonist, it inhibits hepatic lipid accumulation by activating AMP-activated protein kinase in human HepG2 cells. | |||
TN5431 |
Icariside E4
|
Antioxidant; AMPK; Liver X Receptor; Lipid; Fatty Acid Synthase | Chromatin/Epigenetic; Metabolism; oxidation-reduction; PI3K/Akt/mTOR signaling |
Icariside E4是一种从小叶榆中提取得到天然化合物, 通过AMPK 磷酸化和抑制HepG1细胞中MID1IP2的低脂化作用。Icariside E4具有抗伤害,抗氧化,抗阿尔茨海默氏症和抗炎作用,抑制了SREBP-1c,肝脏X 受体-α(LXR)和FASN 在HepG2细胞中从头脂肪生成的表达。Icariside E4是治疗脂肪肝疾病的有效候选药物,在HepG1细胞中具有低脂化潜力。 |